Susquehanna International Group LLP Acquires 9,393 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Susquehanna International Group LLP increased its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 31.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 39,593 shares of the company's stock after purchasing an additional 9,393 shares during the quarter. Susquehanna International Group LLP's holdings in Ryan Specialty were worth $2,540,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Hsbc Holdings PLC boosted its stake in shares of Ryan Specialty by 16.4% in the 4th quarter. Hsbc Holdings PLC now owns 3,654 shares of the company's stock worth $234,000 after buying an additional 514 shares during the last quarter. IHT Wealth Management LLC boosted its position in Ryan Specialty by 205.6% in the fourth quarter. IHT Wealth Management LLC now owns 12,097 shares of the company's stock worth $776,000 after purchasing an additional 8,138 shares during the last quarter. Stifel Financial Corp grew its stake in shares of Ryan Specialty by 14.2% during the 4th quarter. Stifel Financial Corp now owns 106,313 shares of the company's stock valued at $6,821,000 after purchasing an additional 13,239 shares during the period. Tower Research Capital LLC TRC increased its position in shares of Ryan Specialty by 386.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,041 shares of the company's stock valued at $644,000 after purchasing an additional 7,976 shares during the last quarter. Finally, MetLife Investment Management LLC lifted its stake in shares of Ryan Specialty by 12.0% in the 4th quarter. MetLife Investment Management LLC now owns 64,413 shares of the company's stock worth $4,133,000 after purchasing an additional 6,883 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Royal Bank of Canada cut their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Barclays lowered their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Wells Fargo & Company reduced their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Finally, TD Cowen started coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $75.67.

Ryan Specialty Price Performance

NYSE:RYAN opened at $70.92 on Thursday. The company has a market capitalization of $18.58 billion, a P/E ratio of 102.79, a P/E/G ratio of 1.19 and a beta of 0.68. The business's 50-day moving average is $70.15 and its 200 day moving average is $68.72. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 12 month low of $52.02 and a 12 month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Ryan Specialty's revenue for the quarter was up 25.0% compared to the same quarter last year. During the same period last year, the firm posted $0.35 earnings per share. On average, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio is 141.18%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.